Related Experiment Video
Updated: Dec 20, 2025
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Effect of Erufosine on Membrane Lipid Order in Breast Cancer Cell Models
Rumiana Tzoneva1, Tihomira Stoyanova1, Annett Petrich2
1Bulgarian Academy of Sciences, Institute of Biophysics and Biomedical Engineering, 1113 Sofia, Bulgaria.
Abstract:
Alkylphospholipids are a novel class of antineoplastic drugs showing remarkable therapeutic potential. Among them, erufosine (EPC3) is a promising drug for the treatment of several types of tumors. While EPC3 is supposed to exert its function by interacting with lipid membranes, the exact molecular mechanisms involved are not known yet. In this work, we applied a combination of several fluorescence microscopy and analytical chemistry approaches (i.e., scanning fluorescence correlation spectroscopy, line-scan fluorescence correlation spectroscopy, generalized polarization imaging, as well as thin layer and gas chromatography) to quantify the effect of EPC3 in biophysical models of the plasma membrane, as well as in cancer cell lines. Our results indicate that EPC3 affects lipid-lipid interactions in cellular membranes by decreasing lipid packing and increasing membrane disorder and fluidity. As a consequence of these alterations in the lateral organization of lipid bilayers, the diffusive dynamics of membrane proteins are also significantly increased. Taken together, these findings suggest that the mechanism of action of EPC3 could be linked to its effects on fundamental biophysical properties of lipid membranes, as well as on lipid metabolism in cancer cells.
Insights
Erufosine (EPC3), an anticancer drug, disrupts cancer cell membranes by increasing fluidity and disorder. This affects lipid interactions and enhances membrane protein movement, suggesting a novel mechanism of action for this antineoplastic agent.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Alkylphospholipids represent a novel class of antineoplastic drugs with significant therapeutic promise.
- Erufosine (EPC3) is a notable alkylphospholipid investigated for its efficacy against various tumors.
- The precise molecular mechanisms underlying erufosine's action, particularly its interaction with lipid membranes, remain largely unelucidated.
Purpose of the Study:
- To investigate the molecular mechanisms of erufosine (EPC3) by quantifying its effects on biophysical models of the plasma membrane and cancer cell lines.
- To elucidate how erufosine influences lipid-lipid interactions, membrane organization, and membrane protein dynamics.
- To explore the potential link between erufosine's biophysical effects and its antineoplastic activity.
Main Methods:
- Utilized advanced fluorescence microscopy techniques, including scanning fluorescence correlation spectroscopy (sFCS) and line-scan fluorescence correlation spectroscopy (LS-FCS).
- Employed generalized polarization (GP) imaging to assess membrane properties.
- Integrated analytical chemistry methods such as thin-layer chromatography (TLC) and gas chromatography (GC) for lipid analysis.
Main Results:
- Erufosine (EPC3) was found to decrease lipid packing and increase membrane disorder and fluidity in cellular membranes.
- Significant alterations in the lateral organization of lipid bilayers were observed upon EPC3 treatment.
- The diffusive dynamics of membrane proteins were markedly increased as a consequence of EPC3-induced membrane changes.
Conclusions:
- Erufosine (EPC3) exerts its effects by modulating fundamental biophysical properties of lipid membranes.
- The observed changes in membrane fluidity, lipid packing, and protein diffusion suggest a novel mechanism of action for EPC3.
- Findings indicate that erufosine's antineoplastic activity may be associated with its impact on membrane biophysics and lipid metabolism in cancer cells.
